nomifensine

Trade name: Merital

Small moleculewithdrawn

Approved

Jun 1, 1984

Nomifensine, formerly sold under the brand names Merital and Alival, is a norepinephrine–dopamine reuptake inhibitor (NDRI) drug that was developed in the 1960s by Hoechst AG, who then test marketed it in the United States. — Wikipedia

Clinical trial activity

0 trials · 0 clinical orgs · 1 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0

Timeline

1980s

  1. Jun 1, 1984

    Earliest FDA Approval

Indications

Mechanism of action

Approval history

  • withdrawnJun 1, 1984

Chemistry & pharmacology

Loading structure…

SMILES

CN1Cc2c(N)cccc2C(c2ccccc2)C1
Mol. weight
238.33 g/mol
Lipinski Ro5
Pass
Rule of 3
Yes
Chirality
Racemic Mixture
Inorganic
No
Polymer
No
Delivery
Oral
Availability
Discontinued

Oral

Yes

Parenteral

No

Topical

No

Sources

Also known as

  • 2-methyl-4-phenyl-1,2,3,4-tetrahydro-8-isoquinolinamine
  • 2-methyl-4-phenyl-1,2,3,4-tetrahydro-8-isoquinolinamine
  • 8-amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisochinolin
  • 8-amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisochinolin
  • 8-amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisoquinoline
  • 8-amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisoquinoline
  • 8-amino-2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline
  • 8-amino-2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline
  • hoe-984
  • hoe-984
  • linamiphen
  • merital
  • merital
  • merital
  • merital
  • merital
  • merital
  • merital
  • nomifensin
  • nomifensin
  • nomifensin
  • (+-)-nomifensin
  • (+-)-nomifensin
  • (+/-)-nomifensin
  • nomifensina
  • nomifensina
  • nomifensine
  • nomifensine
  • nomifensine
  • nomifensine
  • nomifensine
  • nomifensine
  • nomifensine
  • nomifensine
  • (+-)-nomifensine
  • (+-)-nomifensine
  • (+/-)-nomifensine
  • (+)-nomifensine
  • (+)-nomifensine
  • nomifensine maleate
  • nomifensine maleate
  • nomifensine maleate
  • nomifensinum
  • nomifensinum
  • (+)-nomiphensine
  • (+)-nomiphensine
  • (r)-1,2,3,4-tetrahydro-2-methyl-4-phenyl-8-isoquinolinamine
  • (r)-1,2,3,4-tetrahydro-2-methyl-4-phenyl-8-isoquinolinamine

Organizations

Marketing (1)

OrganizationOrg typeRelationshipDate
HoechstFor profitNDA